Biarison in the treatment of degenerative joint diseases: comparison with indomethacin and placebo.
D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002493:Central Nervous System Diseases / Q000139:chemically induced; D004311:Double-Blind Method; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010003:Osteoarthritis / Q000188:drug therapy*; D010919:Placebos; D011799:Quinazolines / Q000009:adverse effects / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D010919:Placebos; D011799:Quinazolines; C011385:proquazone; D007213:Indomethacin